Sutro Biopharma Inc (STRO)
3.83
-0.11
(-2.79%)
USD |
NASDAQ |
May 03, 16:00
3.84
+0.01
(+0.26%)
After-Hours: 20:00
Sutro Biopharma Revenue (TTM): 153.73M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 153.73M |
| September 30, 2023 | 48.64M |
| June 30, 2023 | 56.86M |
| March 31, 2023 | 74.55M |
| December 31, 2022 | 67.77M |
| September 30, 2022 | 69.79M |
| June 30, 2022 | 53.16M |
| March 31, 2022 | 53.12M |
| December 31, 2021 | 61.88M |
| September 30, 2021 | 59.50M |
| June 30, 2021 | 68.81M |
| March 31, 2021 | 50.23M |
| Date | Value |
|---|---|
| December 31, 2020 | 42.72M |
| September 30, 2020 | 45.75M |
| June 30, 2020 | 40.20M |
| March 31, 2020 | 41.26M |
| December 31, 2019 | 42.74M |
| September 30, 2019 | 50.52M |
| June 30, 2019 | 46.08M |
| March 31, 2019 | 41.26M |
| December 31, 2018 | 38.42M |
| September 30, 2018 | 23.37M |
| June 30, 2018 | 33.04M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
40.20M
Minimum
Jun 2020
153.73M
Maximum
Dec 2023
59.33M
Average
53.12M
Median
Mar 2022
Revenue (TTM) Benchmarks
| AnaptysBio Inc | 17.16M |
| ABVC BioPharma Inc | 0.1524M |
| Reviva Pharmaceuticals Holdings Inc | -- |
| Flora Growth Corp | 76.86M |
| Journey Medical Corp | 79.18M |